LineaRx agreement with Takis and Evvivax for cancer vaccines
September 21st, 2018
News
All Categories
ACDL
APDN in the News
CertainT®
Coronavirus
Corporate/Financial News
Investors
Large-Scale DNA Production
Linear DNA
mpox
PGx
Press Release
Uncategorized
Vaccines
Pharmaceutical Technology | LineaRx signs drug development agreement with Takis
September 21st, 2018
Creating Thread DNA to Ensure Apparel Authenticity
September 21st, 2018
LineaRx to Collaborate with Takis and Evvivax on Cancer Vaccines
September 20th, 2018
Applied DNA Subsidiary, LineaRx, Inc. Signs Joint Development Agreement with Takis and Evvivax to Develop Linear-DNA Based Anti-Cancer Vaccines
September 20th, 2018
With New Spinoff, Biotech Goes All-In On DNA Sales
September 19th, 2018
APDN Forms Subsidiary, LineaRx, to Develop DNA for Biotherapeutics
September 18th, 2018
APDN’s new 2-year contract with the US Defense Logistics Agency
September 12th, 2018
APDN Executes 2 Yr Contract with US Defense Logistics Agency
September 12th, 2018